Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abiomed Inc (NQ: ABMD )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abiomed Inc

< Previous 1 2 3 4 5 Next >
Beat the Dow Jones With This Unstoppable Dividend Stock
Johnson & Johnson has outperformed the Dow so far this year. 
Via The Motley Fool
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
A mixed jobs report and heavy earnings swung stocks. 
Via Investor's Business Daily
Here's How Much $100 Invested In Abiomed 20 Years Ago Would Be Worth Today
Abiomed (NASDAQ:ABMD) has outperformed the market over the past 20 years by 18.13% on an annualized basis producing an average annual return of 25.63%. Currently, Abiomed has a market capitalization of... 
Via Benzinga
5 Analysts Have This to Say About Abiomed
Over the past 3 months, 5 analysts have published their opinion on Abiomed (NASDAQ:ABMD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Upgrades 
Via Benzinga
Is Johnson & Johnson an Underrated Growth Stock?
Johnson & Johnson trades at a modest earnings multiple, and it may warrant a premium. 
Via The Motley Fool
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
ABIOMED INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abiomed, Inc. - ABMD
From Kahn Swick & Foti, LLC
Via Business Wire
Why Abiomed Stock Skyrocketed Today
A healthcare titan wants to acquire the medical technology specialist for a whopping $16.6 billion. 
Via The Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
As the exodus out of mega-cap technology stocks continues, investors and money managers are looking for other sectors to rotate into. 
Via Benzinga
10 Best Stocks to Buy Now in November
These beaten-down growth stocks have significant upside. 
Via The Motley Fool
Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 70 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Investors Wary Of Potential Fed Response To Resilient Labor Market
Stocks are pulling back from their morning gains, following data that showed U.S. job openings rose to 10.7 million in September. 
Via Talk Markets
Johnson & Johnson (NYSE: JNJ) Set to Acquire Abiomed (NASDAQ: ABMD) for $16.6 Billion or $380 per Share Plus CVR
Abiomed, Inc. (NASDAQ: ABMD) is engaged as a medical technology company, which is focused on providing support and resources to 
Via Spotlight Growth
Exposures Product Safety
Dow Drops Over 200 Points; Crude Oil Rises Sharply
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Tuesday. 
Via Benzinga
Why Is Uber Stock Up Today?
Uber (UBER) stock is on the move Tuesday as investors react to results from the company's earnings report for the third quarter of 2022. 
Via InvestorPlace
Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session
Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads. 
Via Benzinga
US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views
U.S. stocks traded lower this morning, with the Dow Jones dropping around 80 points on Tuesday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Why Is Carvana (CVNA) Stock Up 15% Today?
Carvana (CVNA) stock is climbing higher on Tuesday after JPMorgan analyst Rajat Gupta upgraded the company's shares to neutral. 
Via InvestorPlace
Why Is Abiomed (ABMD) Stock Up 50% Today?
Abiomed will become part of Johnson & Johnson's huge medical devices unit after being bought for $16.6 billion in cash. 
Via InvestorPlace
Johnson & Johnson Expands Cardiovascular Portfolio, Bets $16B In Abiomed's Heart Failure Devices
Via Benzinga
Uber Rides Higher, but Here's Tuesday's Big Stock Winner
Earnings are only part of the story. 
Via The Motley Fool
Recap: Abiomed Q2 Earnings
Abiomed (NASDAQ:ABMD) reported its Q2 earnings results on Tuesday, November 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Abiomed beat estimated earnings by... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning! 
Via InvestorPlace
ABMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ABIOMED, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year
From Abiomed, Inc.
Via Business Wire
Johnson & Johnson to Acquire Abiomed
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.